Search

Did you mean
here+
Your search for "HER2+" gave back 20 results.
HER2-Positive Early Breast Cancer Overview "HER2-Positive Early Breast Cancer Pipeline Insight, 2020" Report By DelveInsight Outlays...
Catalog: 
Delveinsight
February 2020
Price: USD 2,500.00
Metastatic HER2 positive breast cancer Overview "Metastatic HER2 positive breast cancer Pipeline Insight, 2020" Report By DelveInsight...
Catalog: 
Delveinsight
February 2020
Price: USD 2,000.00
Hormone Receptor (HR) positive/ Human Epidermal Receptor 2 (HER2) negative Breast Cancer-Market Insights, Epidemiology and Market Forecast–2030...
Delveinsight
May 2020
Price: USD 6,950.00
Overview "Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitor - Pipeline Insight, 2020" report by publisher outlays...
Catalog: 
Delveinsight
July 2020
Price: USD 1,500.00
Hormone Receptor (HR)-positive/ Human Epidermal Receptor 2 (HER2)-negative Breast Cancer- Market Insights, Epidemiology and Market Forecast–2028...
Catalog: 
Delveinsight
September 2019
Price: USD 6,250.00
Hormone Receptor (HR)-positive/ Human Epidermal Receptor 2 (HER2)-negative Breast Cancer- Epidemiology Forecast–2028 report delivers an in-depth...
Catalog: 
Delveinsight
September 2019
Price: USD 3,250.00
Anti-Her2 Antibody-Drug Conjugates in: September 2016 R&D and Business Tracker for Antibody-Drug Conjugates This pdf report contains information...
La Merie Publishing
October 2016
Price: USD 225.00
Trastuzumab– Biosimilar Insight, 2020 report provides comprehensive insights about 35+ companies and 35+ marketed and pipeline drugs in Trastuzumab...
Catalog: 
Delveinsight
September 2020
Price: USD 2,500.00
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic...
La Merie Publishing
March 2014
Price: USD 1,514.00
Kisqali (ribociclib) - Drug Insight and Market Forecast – 2030 report by DelveInsight outlays comprehensive insights of the product indicated for the...
Catalog: 
Delveinsight
August 2020
Price: USD 2,750.00
Ibrance– Drug Insight and Market Forecast — 2030 report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of...
Catalog: 
Delveinsight
August 2020
Price: USD 2,750.00
DelveInsight’s, “EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) – Pipeline Insight, 2020,” report provides comprehensive insights about 30+ companies...
Catalog: 
Delveinsight
September 2020
Price: USD 2,000.00
Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases This Competitive Intelligence report about Bispecific Antibodies...
La Merie Publishing
June 2019
Price: USD 900.00
Women’s Health - Assessing the Need for a Targeted and Specialized Approach Summary Many of the diseases and conditions that affect mainly women are...
CBR Pharma Insights
January 2015
Price: USD 2,995.00
Overview “Afinitor (everolimus) - Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product...
Catalog: 
Delveinsight
August 2020
Price: USD 2,750.00

Contact Us for Custom Market Research Solutions

 

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected